Stocks and Investing Stocks and Investing
Fri, July 12, 2024

Michael Ulz Maintained (BPMC) at Hold with Increased Target to $115 on, Jul 12th, 2024


Published on 2024-10-28 12:24:37 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $110 to $115 on, Jul 12th, 2024.

Michael has made no other calls on BPMC in the last 4 months.



There are 12 other peers that have a rating on BPMC. Out of the 12 peers that are also analyzing BPMC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $75 on, Friday, May 3rd, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024


These are the ratings of the 9 analyists that currently disagree with Michael


  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Monday, July 8th, 2024
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $130 on, Friday, June 28th, 2024
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $125 on, Friday, June 7th, 2024
  • Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $140 on, Tuesday, May 14th, 2024
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
Contributing Sources